PDCD1 and neoplasm: PD1 blockade amplifies the anti-tumour effects of DR by promoting the expansion of effector T cells (Teff and TexEff cells) to limit tumour growth, highlighting the potential to enhance the efficacy of immunotherapies through nutritional intervention.